ArticleSovremennye tekhnologii v meditsine2026
Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics.
K O Avrov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.